Overview
Introduction
The protein therapeutic market is forecast to grow rapidly at a CAGR of 10.5% from 2003 to 2010,
to almost double in value. The increased use, development and discovery of protein therapeutics will
lead to increasing opportunities for drug delivery companies. Pharma companies need to utilize these
technologies to gain a competitive edge in an increasingly crowded therapeutic protein market.
Scope
- Analysis of the protein therapeutics portfolio and pipeline for 50 leading pharma and biotech
companies
- Benchmarking of the current and future protein drug delivery market by technology and
therapeutic focus
- Evaluates the key drivers and resistors of the protein drug delivery market
- Assesses the strategic aims of pharmaceutical companies in utilizing protein drug delivery
technologies
Report Highlights
The protein therapeutic market is largely immediate release, but there is a trend moving towards
increased sustained release formulations. Datamonitor believes that pharmaceutical companies in the
protein therapeutic market should look to in-license suitable technologies to improve the qualities
and potential of their products.
The protein therapeutic market is primarily an injectable arena, but drug delivery companies are
striving to develop non-injectable solutions to the delivery of protein therapeutics.
While the majority of protein therapeutics on the market do not have devices available, this is a
growing segment of the market and Datamonitor expects the growth to accelerate. Datamonitor believes
that companies should explore the use of devices to maximise the potential of their products and
differentiate them from competitors.
Reasons to Purchase
- Understand trends across technological and therapeutic fields to target resources effectively
and recognise pipeline opportunities.
- Identify the opportunities provided by current and future protein drug delivery technologies to
effectively plan your product development.
- Optimise your market penetration through improved knowledge of the growth drivers and corporate
dynamics of the protein drug delivery market.
| 
View Cart
